<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.ann-clinmicrob.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Annals of Clinical Microbiology and Antimicrobials - Latest Articles</title>
        <link>http://www.ann-clinmicrob.com</link>
        <description>The latest research articles published by Annals of Clinical Microbiology and Antimicrobials</description>
        <dc:date>2010-08-13T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/23" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/22" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/21" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/20" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/19" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/18" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/17" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/16" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/15" />
                                <rdf:li rdf:resource="http://www.ann-clinmicrob.com/content/9/1/14" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/23">
        <title>Identification of Staphylococcus aureus: DNase and Mannitol salt agar improve the efficiency of the tube coagulase test</title>
        <description>Background:
The ideal identification of Staphylococcus aureus clinical isolates requires a battery of tests and this is costly in resource limited settings. In many developing countries, the tube coagulase test is usually confirmatory for S. aureus and is routinely done using either human or sheep plasma. This study evaluated Mannitol salt agar and the deoxyribonuclease (DNase) test for improving the efficiency of the tube coagulase test in resource limited settings. The efficiency of human and sheep plasma with tube coagulase tests was also evaluated.
Methods:
One hundred and eighty Gram positive, Catalase positive cocci occurring in pairs, short chains or clusters were subjected to growth on Mannitol salt agar, deoxyribonuclease and tube coagulase tests. Of these, isolates that were positive for at least two of the three tests (n = 60) were used to evaluate the performance of the tube coagulase test for identification of S. aureus, using PCR-amplification of the nuc gene as a gold standard.
Results:
Human plasma was more sensitive than sheep plasma for the tube coagulase test (sensitivity of 91% vs. 81% respectively), but both plasmas had very low specificity (11% and 7% respectively). The sensitivity and specificity of the tube coagulase test (human plasma) was markedly improved when Mannitol salt agar and DNase were introduced as a tri-combination test for routine identification of Staphylococcus aureus (100% specificity and 75% sensitivity). The specificity and sensitivity of Mannitol salt agar/DNase/tube coagulase (sheep plasma) combination was 100% and 67%, respectively.
Conclusion:
The efficiency of the tube coagulase test can be markedly improved by sequel testing of the isolates with Mannitol salt agar, DNase and Tube coagulase. There is no single phenotypic test (including tube coagulase) that can guarantee reliable results in the identification of Staphylococcus aureus.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/23</link>
                <dc:creator>David Kateete</dc:creator>
                <dc:creator>Cyrus Kimani</dc:creator>
                <dc:creator>Fred Katabazi</dc:creator>
                <dc:creator>Alfred Okeng</dc:creator>
                <dc:creator>Moses Okee</dc:creator>
                <dc:creator>Ann Nanteza</dc:creator>
                <dc:creator>Moses Joloba</dc:creator>
                <dc:creator>Florence Najjuka</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:23</dc:source>
        <dc:date>2010-08-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-23</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2010-08-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/22">
        <title>Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.</title>
        <description>Background:
The frequency of primary resistance to antibiotics in H. pylori isolates is increasing worldwide. In Tunisia, there are limited data regarding the pattern of H. pylori antibiotic primary resistance.AimTo evaluate the primary resistance of H. pylori to clarithromycin, metronidazole and amoxicillin and to detect the mutations involved in clarithromycin resistance.Materials and methods273 strains isolated from adults and children were enrolled. The primary resistance to clarithromycin, metronidazole and amoxicillin was evaluated by means of E-test minimal inhibitory concentration (MIC). The real-time PCR using Scorpion primers was performed in all cases to assess clarithromycin primary resistance and point mutations involved.
Results:
No resistance to amoxicillin was detected. For adults, resistance to clarithromycin and metronidazole was found respectively in 14.6% and 56.8%, and respectively in 18.8% and 25% in children. Overall, the rates of global primary resistance to clarithromycin and metronidazole in Tunisia were respectively determined in 15.4% and 51.3%.By the use of Scorpion PCR, the A2143G was the most frequent point mutation observed (88.1%), followed by the A2142G (11.9%); the A2142C was not found and 18 of 42 patients (42.8%) were infected by both the resistant and the susceptible genotype.The association of clarithromycin resistance with gender was not statistically significant, but metronidazole resistant strains were isolated more frequently in females (67.8%) than in males (32.2%) and the difference was significant. As for gastroduodenal diseases, the difference between strains isolated from patients with peptic ulceration and those with non peptic ulceration was not statistically significant. When about the distribution of resistant strains to clarithromycin and metronidazole between the three Tunisian cities (Tunis, Menzel Bourguiba and Mahdia), the difference was not statistically significant.
Conclusion:
Local data regarding the primary resistance of H. pylori to clarithromycin, metronidazole and amoxicillin and the main genetic mutation involved in clarithromycin resistance in vivo (A2143G) are necessary to prove a clear need for a periodic evaluation of antibiotic consumption and new therapeutic strategies in Tunisia in order to avoid the emergence of resistant strains.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/22</link>
                <dc:creator>Khansa Ben Mansour</dc:creator>
                <dc:creator>Christophe Burucoa</dc:creator>
                <dc:creator>Meriem Zribi</dc:creator>
                <dc:creator>Afef Masmoudi</dc:creator>
                <dc:creator>Sami Karoui</dc:creator>
                <dc:creator>Lamia Kallel</dc:creator>
                <dc:creator>Soufiene Chouaib</dc:creator>
                <dc:creator>Samira Matri</dc:creator>
                <dc:creator>Monia Fekih</dc:creator>
                <dc:creator>Sonia Zarrouk</dc:creator>
                <dc:creator>Mounir Labbene</dc:creator>
                <dc:creator>Jalel Boubaker</dc:creator>
                <dc:creator>Imed Cheikh</dc:creator>
                <dc:creator>Mongi Ben Hriz</dc:creator>
                <dc:creator>Nadia Siala</dc:creator>
                <dc:creator>Abdelkarim Ayedi</dc:creator>
                <dc:creator>Azza Filali</dc:creator>
                <dc:creator>Nabil Ben Mami</dc:creator>
                <dc:creator>Taoufik Najjar</dc:creator>
                <dc:creator>Ahmed Maherzi</dc:creator>
                <dc:creator>Mohamed Tahar Sfar</dc:creator>
                <dc:creator>Chedlia Fendri</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:22</dc:source>
        <dc:date>2010-08-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-22</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2010-08-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/21">
        <title>Rapid detection of Pseudomonas aeruginosa from positive blood cultures by quantitative PCR</title>
        <description>Background:
Pseudomonas aeruginosa is responsible for numerous bloodstream infections associated with severe adverse outcomes in case of inappropriate initial antimicrobial therapy. The present study was aimed to develop a novel quantitative PCR (qPCR) assay, using ecfX as the specific target gene, for the rapid and accurate identification of P. aeruginosa from positive blood cultures (BCs).
Methods:
Over the period August 2008 to June 2009, 100 BC bottles positive for gram-negative bacilli were tested in order to evaluate performances of the qPCR technique with conventional methods as gold standard (i.e. culture and phenotypic identification).
Results:
Thirty-three strains of P. aeruginosa, 53 strains of Enterobactericaeae, nine strains of Stenotrophomonas maltophilia and two other gram-negative species were isolated while 3 BCs were polymicrobial including one mixture containing P. aeruginosa. All P. aeruginosa clinical isolates were detected by qPCR except a single strain in mixed culture. Performances of the qPCR technique were: specificity, 100%; positive predictive value, 100%; negative predictive value, 98.5%; and sensitivity, 97%.
Conclusions:
This reliable technique may offer a rapid (&lt;1.5 h) tool that would help clinicians to initiate an appropriate treatment earlier. Further investigations are needed to assess the clinical benefit of this novel strategy as compared to phenotypic methods.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/21</link>
                <dc:creator>Vincent Cattoir</dc:creator>
                <dc:creator>Audrey Gilibert</dc:creator>
                <dc:creator>Jeanne-Marie Le Glaunec</dc:creator>
                <dc:creator>Nathalie Launay</dc:creator>
                <dc:creator>Lilia Bait-Merabet</dc:creator>
                <dc:creator>Patrick Legrand</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:21</dc:source>
        <dc:date>2010-08-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-21</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2010-08-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/20">
        <title>The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta</title>
        <description>Background:
Antibiotic resistance is an increasing problem in isolates of Staphylococcus aureus (S. aureus) worldwide. In 2001 The National Health Service in the UK introduced a mandatory bacteraemia surveillance scheme for the reporting of S. aureus and methicillin-resistant S. aureus (MRSA). This surveillance initiative reports on the percentage of isolates that are methicillin resistant. However, resistance to other antibiotics is not currently reported and therefore the scale of emerging resistance is currently unclear in the UK. In this study, multiple antibiotic resistance (MAR) profiles against fourteen antimicrobial drugs were investigated for 705 isolates of S. aureus collected from two European study sites in the UK (London) and Malta.
Results:
All isolates were susceptible to linezolid, teicoplanin and vancomycin. Multiple antibiotic resistance profiles from both countries were determined, a total of forty-two and forty-five profiles were seen in the UK cohort (MRSA and MSSA respectively) and comparatively, sixty-two and fifty-two profiles were shown in the Maltese group. The largest MAR profile contained six antibiotics (penicillin G, methicillin, erythromycin, ciprofloxacin, clindamycin and clarithromycin) and was observed in the MRSA isolates in both the UK and Maltese cohorts.
Conclusion:
The data presented here suggests that the monitoring of changing resistance profiles locally in maintaining treatment efficacy to resistant pathogens.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/20</link>
                <dc:creator>Simon Gould</dc:creator>
                <dc:creator>Paul Cuschieri</dc:creator>
                <dc:creator>Jess Rollason</dc:creator>
                <dc:creator>Anthony Hilton</dc:creator>
                <dc:creator>Sue Easmon</dc:creator>
                <dc:creator>Mark Fielder</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:20</dc:source>
        <dc:date>2010-07-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-20</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>20</prism:startingPage>
        <prism:publicationDate>2010-07-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/19">
        <title>Frequency of conjugative transfer of plasmid-encoded ISEcp1 - blaCTX-M-15 and aac(6&apos;)-lb-cr genes in Enterobacteriaceae at a tertiary care center in Lebanon - role of transferases </title>
        <description>Background:
The frequency of transfer of genes encoding resistance to antimicrobial agents was determined by conjugation in ESBL-producing and/or fluoroquinolone or aminoglycoside resistant Enterobacteriaceae clinical isolates at a tertiary care center in Lebanon. In addition, the role of tra genes encoding transferases in mediating conjugation was assessed.
Methods:
Conjugation experiments were done on 53 ESBL-producing and/or fluoroquinolone resistant E. coli and K. pneumoniae and ESBL-producing S. sonnei isolates. Antimicrobial susceptibility testing on parent and transconjugant isolates, and PCR amplifications on plasmid extracts of the resistance-encoding genes: blaCTX-M-15 with the ISEcp1 insertion sequence, the aac(6&apos;)-lb-cr and qnrS genes, as well as tra encoding transferases genes were done. Random amplified polymorphic DNA (RAPD) analysis was performed to demonstrate whether conjugative isolates are clonal and whether they are linked epidemiologically to a particular source.
Results:
Antimicrobial susceptibility testing on transconjugants revealed that 26 out of 53 (49%) ESBL-producing Enterobacteriaceae were able to transfer antimicrobial resistance to the recipients. Transfer of high-level resistance to the transconjugants encoded by the blaCTX-M-15 gene downstream the ISEcp1 insertion sequence against 3rd generation cephalosporins, and of low-level resistance against ciprofloxacin, and variable levels of resistance against aminoglycosides encoded by aac(6&apos;)-lb-cr gene, were observed in transconjugants. tra encoding transferase genes were detected exclusively in conjugative isolates.
Conclusion:
In conclusion, the frequency of transfer of antimicrobial resistance in non clonal Enterobacteriaceae at the tertiary care center by conjugation was 49%. Conjugation occurred in isolates expressing the tra encoding transferase genes. Multiple conjugative strains harboring the plasmid encoded antimicrobial resistant genes were circulating in the medical center. Molecular epidemiology analysis showed that conjugative isolates are neither clonal nor linked to a particular site and transfer of antimicrobial resistance is by horizontal transfer of plasmids.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/19</link>
                <dc:creator>Mohamad Harajly</dc:creator>
                <dc:creator>Marie-Therese Khairallah</dc:creator>
                <dc:creator>John Corkill</dc:creator>
                <dc:creator>George Araj</dc:creator>
                <dc:creator>Ghassan Matar</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:19</dc:source>
        <dc:date>2010-07-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-19</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2010-07-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/18">
        <title>A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa</title>
        <description>Background:
Chronic lung infection with the bacterium Pseudomonas aeruginosa is one of the hallmarks of cystic fibrosis (CF) and is associated with worsening lung function, increased hospitalisation and reduced life expectancy. A virulent clonal strain of P. aeruginosa (Australian epidemic strain I; AES-I) has been found to be widespread in CF patients in eastern Australia.
Methods:
Suppression subtractive hybridization (SSH) was employed to identify genetic sequences that are present in the AES-I strain but absent from the sequenced reference strain PAO1. We used PCR to evaluate the distribution of several of the AES-I loci amongst a collection of 188 P. aeruginosa isolates which was comprised of 35 AES-I isolates (as determined by PFGE), 78 non-AES-I CF isolates including other epidemic CF strains as well as 69 P. aeruginosa isolates from other clinical and environmental sources.
Results:
We have identified a unique AES-I genetic locus that is present in all 35 AES-I isolates tested and not present in any of the other 153 P. aeruginosa strains examined. We have used this unique AES-I locus to develop a diagnostic PCR and a real-time PCR assay to detect the presence of P. aeruginosa and AES-I in patient sputum samples.
Conclusions:
We have developed diagnostic PCR assays that are 100% sensitive and 100% specific for the P. aeruginosa strain AES-I. We have also shown that Whatman FTA&#174; Elute cards may be used with PCR-based assays to rapidly detect the presence of P. aeruginosa strains in CF sputum.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/18</link>
                <dc:creator>Heidi Williams</dc:creator>
                <dc:creator>Lynne Turnbull</dc:creator>
                <dc:creator>Susan Thomas</dc:creator>
                <dc:creator>Anna Murphy</dc:creator>
                <dc:creator>Tim Stinear</dc:creator>
                <dc:creator>David Armstrong</dc:creator>
                <dc:creator>Cynthia Whitchurch</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:18</dc:source>
        <dc:date>2010-07-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-18</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>18</prism:startingPage>
        <prism:publicationDate>2010-07-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/17">
        <title>Dissemination of multidrug resistant Acinetobacter baumanii in various hospitals of Antananarivo, Madagascar</title>
        <description>This study reports the dissemination of multidrug-resistant (MDR) OXA-23-producing Acinetobacter baumannii clones in hospitals in Antananarivo, Madagascar. A total of 53 carbapenem-resistant A. baumannii isolates were obtained from September 2006 to March 2009 in five hospitals. These resistant strains represent 44% of all A. baumannii isolates. The double disk synergy test was performed to screen for production of metallo-beta-lactamases. Polymerase chain reaction (PCR) and DNA sequencing were performed for the detection of bla(AmpC), bla(OXA-51),bla(OXA-23), bla(OXA-24), bla(IMP), bla(VIM). The presence of the insertion sequence ISAba1 relative to blaOXA-23 and blaOXA-51 was assessed by PCR. Isolates were typed by Rep-PCR. All the isolates were MDR and produced the OXA-23 carbapenemase, which was confirmed by sequencing. PCR analysis for AmpC and OXA-51 gave positive results for all strains studied. No isolates produced metallo-beta-lactamases. In all isolates ISAba1 laid upstream of blaOXA-23. The A. baumannii isolates were separated into two genotypes; genotype A had a higher prevalence (41 strains) than genotype B (12 strains). Genotype A was present in four hospitals, whilst genotype B had spread in two hospitals. The high frequency of MDR OXA-23-producing A. baumannii in various hospitals in Antananarivo is curious since carbapenems are not available in Madagascar, but it emphasises the need for infection control procedures and strict adherence to them to prevent the spread of these resistant organisms in Antananarivo and also the need to control the use of carbapenems in the future.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/17</link>
                <dc:creator>Tahiry Andriamanantena</dc:creator>
                <dc:creator>Elisoa Ratsima</dc:creator>
                <dc:creator>Hanitra Rakotonirina</dc:creator>
                <dc:creator>Frederique Randrianirina</dc:creator>
                <dc:creator>Lovasoa Ramparany</dc:creator>
                <dc:creator>Jean-Francois Carod</dc:creator>
                <dc:creator>Vincent Richard</dc:creator>
                <dc:creator>Antoine Talarmin</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:17</dc:source>
        <dc:date>2010-06-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-17</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>17</prism:startingPage>
        <prism:publicationDate>2010-06-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/16">
        <title>Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation</title>
        <description>Background:
Coagulase-negative staphylococci are major causes of bloodstream infections in very low birth weight babies cared for in Neonatal Intensive Care Units. The virulence of these bacteria is mainly due to their ability to form biofilms on indwelling medical devices. Biofilm-related infections often fail to respond to antibiotic chemotherapy guided by conventional antibiotic susceptibility tests.
Methods:
Coagulase-negative staphylococcal blood culture isolates were grown in different phases relevant to biofilm formation: planktonic cells at mid-log phase, planktonic cells at stationary phase, adherent monolayers and mature biofilms and their susceptibilities to conventional antibiotics were assessed. The effects of oxacillin, gentamicin, and vancomycin on preformed biofilms, at the highest achievable serum concentrations were examined. Epifluorescence microscopy and confocal laser scanning microscopy in combination with bacterial viability staining and polysaccharide staining were used to confirm the stimulatory effects of antibiotics on biofilms.
Results:
Most coagulase-negative staphylococcal clinical isolates were resistant to penicillin G (100%), gentamicin (83.3%) and oxacillin (91.7%) and susceptible to vancomycin (100%), ciprofloxacin (100%), and rifampicin (79.2%). Bacteria grown as adherent monolayers showed similar susceptibilities to their planktonic counterparts at mid-log phase. Isolates in a biofilm growth mode were more resistant to antibiotics than both planktonic cultures at mid-log phase and adherent monolayers; however they were equally resistant or less resistant than planktonic cells at stationary phase. Moreover, for some cell-wall active antibiotics, concentrations higher than conventional MICs were required to prevent the establishment of planktonic cultures from biofilms. Finally, the biofilm-growth of two S. capitis isolates could be enhanced by oxacillin at the highest achievable serum concentration.
Conclusion:
We conclude that the resistance of coagulase-negative staphylococci to multiple antibiotics initially remain similar when the bacteria shift from a planktonic growth mode into an early attached mode, then increase significantly as the adherent mode further develops. Furthermore, preformed biofilms of some CoNS are enhanced by oxacillin in a dose-dependent manner.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/16</link>
                <dc:creator>Yue Qu</dc:creator>
                <dc:creator>Andrew Daley</dc:creator>
                <dc:creator>Taghrid Istivan</dc:creator>
                <dc:creator>Suzanne Garland</dc:creator>
                <dc:creator>Margaret Deighton</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:16</dc:source>
        <dc:date>2010-05-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-16</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2010-05-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/15">
        <title>Hospital infection after major amputations</title>
        <description>The aim of the current study was to evaluate the prevalence of stump infections after major amputations of the lower extremities.Patients rehospitalized in Hospital de Base of the Medicine School in S&#227;o Jos&#233; do Rio Preto in the period from January 2005 to January 2007 due to stump infection after major amputations of lower extremities were evaluated in a retrospective study. All the patients underwent prophylactic antibiotic therapy at the time of the surgery. The Fisher exact test was utilized for statistical analysis with an alpha error of 5% (p-value &lt; 0.05) being considered acceptable.A total of 231 patients were submitted to major amputations during this period and 17 (7.3%) were rehospitalized due to amputation stump infections of which 5 (29.4%) died within one month. The association between death due to stump infection and other causes of death during rehospitalizations was not significant (Fisher exact test: p &lt; 0.1). However, death during rehospitalizations was significantly higher than in the initial hospitalization.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/15</link>
                <dc:creator>Jose Maria Pereira de Godoy</dc:creator>
                <dc:creator>Janilice Vasconcelos Ribeiro</dc:creator>
                <dc:creator>Livia Andrioli Caracanhas</dc:creator>
                <dc:creator>Maria de Fatima Guerreiro Godoy</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:15</dc:source>
        <dc:date>2010-05-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-15</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2010-05-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.ann-clinmicrob.com/content/9/1/14">
        <title>A fast and highly sensitive blood culture PCR method for clinical detection of Salmonella enterica  serovar Typhi </title>
        <description>Background:
Salmonella Typhi causes an estimated 21 million new cases of typhoid fever and 216,000 deaths every year. Blood culture is currently the gold standard for diagnosis of typhoid fever, but it is time-consuming and takes several days for isolation and identification of causative organisms. It is then too late to initiate proper antibiotic therapy. Serological tests have very low sensitivity and specificity, and no practical value in endemic areas. As early diagnosis of the disease and prompt treatment are essential for optimal management, especially in children, a rapid sensitive detection method for typhoid fever is urgently needed. Although PCR is sensitive and rapid, initial research indicated similar sensitivity to blood culture and lower specificity. We developed a fast and highly sensitive blood culture PCR method for detection of Salmonella Typhi, allowing same-day initiation of treatment after accurate diagnosis of typhoid.
Methods:
An ox bile tryptone soy broth was optimized for blood culture, which allows the complete lysis of blood cells to release intracellular bacteria without inhibiting the growth of Salmonella Typhi. Using the optimised broth Salmonella Typhi bacteria in artificial blood samples were enriched in blood culture and then detected by a PCR targeting the fliC-d gene of Salmonella Typhi.
Results:
Tests demonstrated that 2.4% ox bile in blood culture not only lyzes blood cells completely within 1.5 hours so that the intracellular bacteria could be released, but also has no inhibiting effect on the growth of Salmonella Typhi.Three hour enrichment of Salmonella Typhi in tryptone soya broth containing 2.4% ox bile could increase the bacterial number from 0.75 CFU per millilitre of blood which is similar to clinical typhoid samples to the level which regular PCR can detect. The whole blood culture PCR assay takes less than 8 hours to complete rather than several days for conventional blood culture.
Conclusions:
This novel blood culture PCR method is superior in speed and sensitivity to both conventional blood culture and PCR assays. Its use in clinical diagnosis may allow early detection of the causative organism and facilitate initiation of prompt treatment among patients with typhoid fever.</description>
        <link>http://www.ann-clinmicrob.com/content/9/1/14</link>
                <dc:creator>Liqing Zhou</dc:creator>
                <dc:creator>Andrew Pollard</dc:creator>
                <dc:source>Annals of Clinical Microbiology and Antimicrobials 2010, 9:14</dc:source>
        <dc:date>2010-04-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1476-0711-9-14</dc:identifier>
        <prism:publicationName>Annals of Clinical Microbiology and Antimicrobials</prism:publicationName>
        <prism:issn>1476-0711</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2010-04-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
